Close this search box.

Clinical Trial: NRG B-51

NRG B-51

Status: Closed

A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy

NSABP B-51 is permanently closed to accrual on December 28, 2020.